Taro Iguchi

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 8

Top Venues

IJU case reports

International journal of clinical oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Current medical research and opinion

Osaka City University

Osaka City University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Osaka City University Jul 01 2008

Japan

Associate Professor :: Urology

SUNY Upstate Medical University May 01 2006 - Jun 30 2008

United States

Research Fellow :: Urology

Education History

Osaka City University Apr 01 2000 - Mar 31 2004

Japan

PHD :: Urology

Publications

Andrew J Armstrong, Arun A Azad, Taro Iguchi, Russell Z Szmulewitz, Daniel P Petrylak, Jeffrey Holzbeierlein, Arnauld Villers, Antonio Alcaraz, Boris Alekseev, Neal D Shore, Francisco Gomez-Veiga, Brad Rosbrook, Fabian Zohren, Shunsuke Yamada, Gabriel P Haas, Arnulf Stenzl
Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (15) (2022)
Taro Iguchi, Yusuke Nakamura, Takeshi Akiyama, Krishant Chand, Eric Yu
Descriptive study on burden and communication of fatigue among castration-resistant prostate cancer patients in Japan. Current medical research and opinion 38 (3) (2021)
Yukiyoshi Hirayama, Taro Iguchi
Editorial Comment from Dr Hirayama and Dr Iguchi to Cranial nerve palsy caused by metastasis to the skull base in patients with castration-resistant prostate cancer: Three case reports. IJU case reports 4 (2) (2021)
Taro Iguchi, Go Kimura, Satoshi Fukasawa, Hiroyoshi Suzuki, Hiroji Uemura, Kazuo Nishimura, Hiroaki Matsumoto, Akira Yokomizo, Andrew J Armstrong, Brad Rosbrook, Jennifer Sugg, Benoit Baron, Lucy Chen, Futoshi Kunieda, Arnulf Stenzl
Enzalutamide with androgen deprivation therapy in Japanese men with metastatic hormone-sensitive prostate cancer: A subgroup analysis of the phase III ARCHES study. International journal of urology : official journal of the Japanese Urological Association 28 (7) (2021)
Yukiyoshi Hirayama, Taro Iguchi
Editorial Comment to Nonmetastatic castration-resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy. IJU case reports 4 (4) (2021)
Taro Iguchi, Akinori Minami
Editorial Comment to Microscopic pulmonary tumor embolism from adenocarcinoma of the prostate. IJU case reports 3 (5) (2020)
Taro Iguchi, Satoshi Tamada, Minoru Kato, Sayaka Yasuda, Yuichi Machida, Tetsuji Ohmachi, Keiichi Ishii, Hiroyuki Iwata, Shinji Yamamoto, Tomohiro Kanamaru, Kazuya Morimoto, Taro Hase, Koichiro Tashiro, Koji Harimoto, Takashi Deguchi, Takahisa Adachi, Katsuki Iwamoto, Yoshinori Takegaki, Tatsuya Nakatani
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: the OCUU-CRPC study. International journal of clinical oncology 25 (3) (2019)
Taro Iguchi, Satoshi Tamada, Minoru Kato, Sayaka Yasuda, Taiyo Otoshi, Kosuke Hamada, Takeshi Yamasaki, Tatsuya Nakatani
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: a retrospective study. International journal of clinical oncology 24 (7) (2019)

Taro Iguchi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Taro Iguchi